Dutch chocolate ice cream recalled

Feb 21, 2008

The U.S. Food and Drug Administration announced the voluntary recall of Pierre's brand Dutch Chocolate Ice Cream due to a labeling error.

The FDA said Pierre's Ice Cream Co. of Cleveland initiated the recall because the ice cream might contain undeclared peanut butter cup candies, posing a health risk to people allergic to peanuts.

The recalled 56-ounce purple containers are identified with the code 07320 printed on the rim of the lid. The ice cream was distributed in Ohio, Michigan, Western Pennsylvania and Indiana.

Consumers are advised to discard the ice cream and send the lid of the empty container to the company for a full refund.

Consumers with questions can contact Pierre's at 216- 432-1144.

Copyright 2008 by United Press International

Explore further: New drug sales help boost Novartis Q1 profit (Update)

add to favorites email to friend print save as pdf

Related Stories

NASA image: Volcanoes in Guatemala

8 minutes ago

This photo of volcanoes in Guatemala was taken from NASA's C-20A aircraft during a four-week Earth science radar imaging mission deployment over Central and South America. The conical volcano in the center ...

Phase transiting to a new quantum universe

11 minutes ago

(Phys.org) —Recent insight and discovery of a new class of quantum transition opens the way for a whole new subfield of materials physics and quantum technologies.

Imaging turns a corner

12 minutes ago

(Phys.org) —Scientists have developed a new microscope which enables a dramatically improved view of biological cells.

When things get glassy, molecules go fractal

1 hour ago

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Genetic legacy of rare dwarf trees is widespread

Researchers from Queen Mary University of London have found genetic evidence that one of Britain's native tree species, the dwarf birch found in the Scottish Highlands, was once common in England.

Google+ boss leaving the company

The executive credited with bringing the Google+ social network to life is leaving the Internet colossus after playing a key role there for nearly eight years.

Facebook woos journalists with 'FB Newswire'

Facebook launched Thursday FB Newswire, billed as an online trove of real-time information for journalists and newsrooms to mine while reporting on events or crafting stories.